Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Health care providers face rising risks in privacy, AI and HIPAA enforcement. Find out what hospitals can do now to strengthen compliance efforts.
Learn what’s next from GASB, including new standards, active projects and research that could impact future governmental reporting.
Learn how process level risk assessments for health care organizations leads to stronger governance, improved patient safety and better performance.
Mobile medical units or construction office trailers may qualify businesses for off-highway fuel use credits, reducing tax burdens and saving money.
Managing 1-to-1 devices in schools requires strong internal controls. Discover practical ways to protect district tech and support compliance efforts.
Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.
The U.S. Department of Labor may change financial thresholds and definitions for labor union reporting forms used by officers and organizations.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
Public-sector procurement scandals show how lax vendor controls endanger taxpayer dollars. Learn key red flags and practical steps to reduce risk.
FY 2026 ACA enrollment growth may impact health care valuations. Learn how the shift may shape provider revenue and risk.
Simplify grant compliance with our step-by-step guide. Stay informed and organized to avoid audit risks and maximize funding impact.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.